tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LYPHF Stock Latest News

Luye Pharma Sets March 2026 Board Meeting to Approve 2025 Results
Company AnnouncementsLuye Pharma Sets March 2026 Board Meeting to Approve 2025 Results
6d ago
Luye Pharma Completes RMB1.09 Billion Transfer of 25% Stake in Nanjing Luye to NJ Xinshi
PremiumCompany Announcements
Luye Pharma Completes RMB1.09 Billion Transfer of 25% Stake in Nanjing Luye to NJ Xinshi
2M ago
Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal
PremiumCompany Announcements
Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal
2M ago
Luye Pharma’s Ruoxinlin NDA for Anxiety Disorder Accepted in China, Targeting Major CNS Market Gap
PremiumCompany Announcements
Luye Pharma’s Ruoxinlin NDA for Anxiety Disorder Accepted in China, Targeting Major CNS Market Gap
2M ago
Luye Pharma Adds Independent Director Xia Lian to Nomination Committee
PremiumCompany Announcements
Luye Pharma Adds Independent Director Xia Lian to Nomination Committee
3M ago
Luye Pharma Outlines Board Line-Up and Committee Structure
PremiumCompany AnnouncementsLuye Pharma Outlines Board Line-Up and Committee Structure
3M ago
Luye Pharma Tightens Governance With Updated Nomination Committee Mandate
Premium
Company Announcements
Luye Pharma Tightens Governance With Updated Nomination Committee Mandate
3M ago
Luye Pharma Structures RMB1.09 Billion Nanjing Luye Stake Transfer With Options and Guarantees
Premium
Company Announcements
Luye Pharma Structures RMB1.09 Billion Nanjing Luye Stake Transfer With Options and Guarantees
3M ago
Luye Pharma Grants Nhwa Exclusive China Rights for Three Long-Acting Schizophrenia Drugs
PremiumCompany Announcements
Luye Pharma Grants Nhwa Exclusive China Rights for Three Long-Acting Schizophrenia Drugs
3M ago
Luye Pharma Completes Strategic Issuance of Exchangeable Preference Shares
PremiumCompany Announcements
Luye Pharma Completes Strategic Issuance of Exchangeable Preference Shares
3M ago
Luye Pharma’s Five New Drugs Gain Inclusion in China’s 2025 Reimbursement Lists
PremiumCompany Announcements
Luye Pharma’s Five New Drugs Gain Inclusion in China’s 2025 Reimbursement Lists
4M ago
Luye Pharma Gains FDA Approval for New CNS Drug Trials
PremiumCompany Announcements
Luye Pharma Gains FDA Approval for New CNS Drug Trials
4M ago
Luye Pharma Announces USD150 Million Exchangeable Shares Issuance
PremiumCompany AnnouncementsLuye Pharma Announces USD150 Million Exchangeable Shares Issuance
4M ago
Luye Pharma’s New Phase 1 Study: A Potential Game-Changer in Neurological Treatments
Premium
Company Announcements
Luye Pharma’s New Phase 1 Study: A Potential Game-Changer in Neurological Treatments
5M ago
LYPHF
Luye Pharma’s New Trial on Tardive Dyskinesia: A Potential Game Changer?
Premium
Company Announcements
Luye Pharma’s New Trial on Tardive Dyskinesia: A Potential Game Changer?
5M ago
LYPHF
Luye Pharma’s New Study on LY03017: A Potential Game-Changer in Neuropsychiatric Treatment
PremiumCompany Announcements
Luye Pharma’s New Study on LY03017: A Potential Game-Changer in Neuropsychiatric Treatment
5M ago
LYPHF
Luye Pharma’s Promising Phase III Trial for Relapsed SCLC: A Potential Game-Changer
PremiumCompany Announcements
Luye Pharma’s Promising Phase III Trial for Relapsed SCLC: A Potential Game-Changer
5M ago
LYPHF
Luye Pharma Converts Convertible Bonds to Shares
PremiumCompany Announcements
Luye Pharma Converts Convertible Bonds to Shares
6M ago
Luye Pharma Converts $25 Million of Tranche A Bonds
PremiumCompany Announcements
Luye Pharma Converts $25 Million of Tranche A Bonds
6M ago
Luye Pharma Reports Revenue Growth Amid Profit Decline
PremiumCompany AnnouncementsLuye Pharma Reports Revenue Growth Amid Profit Decline
7M ago
Luye Pharma Reports Mixed Interim Financial Results for 2025
Premium
Company Announcements
Luye Pharma Reports Mixed Interim Financial Results for 2025
7M ago
Luye Pharma Announces Partial Conversion of Convertible Bonds
Premium
Company Announcements
Luye Pharma Announces Partial Conversion of Convertible Bonds
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >